IGM Biosciences Inc (NAS:IGMS)
$ 7.24 -0.07 (-0.96%) Market Cap: 427.33 Mil Enterprise Value: 174.49 Mil PE Ratio: 0 PB Ratio: 2.65 GF Score: 34/100

IGM Biosciences Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 01:15AM GMT
Release Date Price: $20.53 (+8.74%)
Eric William Joseph
JPMorgan Chase & Co, Research Division - VP & Senior Analyst

All right. Good afternoon. I'm Eric Joseph, senior biotech analyst with JPMorgan. Our next presenting company is IGM Biosciences; and presenting on behalf of the company is CEO, Fred Schwarzer. There's a Q&A after the presentation. Just raise your hand. We'll bring a mic around. For those tuning in online, feel free to submit a question via the digital conference book, and we'll work those in where appropriate. So with that, Fred. Thank you.

Fred M. Schwarzer
IGM Biosciences, Inc. - CEO, President & Director

Thanks very much, Eric. Really appreciate the opportunity to talk about IGM Biosciences, perhaps my favorite subject other than my 2 sons, but really appreciate the opportunity today.

So here's our forward-looking statement disclaimer. We are going to talk about some -- make some forward-looking statements, and so I have to refer you to all the risk factors and other disclaimers in our SEC filings.

So IGM Biosciences, as you can guess from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot